| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.004 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |